Once consented, the patients will be randomized to treatment group by random allocation process using Research Randomizer (Urbaniak, G. C., & Plous, S. Version 3.0 Computer software]. The patient and family will be blinded to which sedation is given. Nurses and physicians will not be blinded as they will be administering the sedatives. Although the patients will receive randomized sedation, these patients would be administered either propofol or midazolam even if they were not included in this research. The only modification for research purposes is the randomization of sedation medication by the randomizer rather than the physician. Currently, the providers in the research team do not have a preference of one type of sedation medication over the other.